Regional distribution of the prostaglandin E2 receptor EP1 in the rat brainAccumulation in Purkinje cells of the cerebellum

被引:0
|
作者
Eduardo Candelario-Jalil
Helen Slawik
Ingrid Ridelis
Anne Waschbisch
Ravi Shankar Akundi
Michael Hüll
Bernd L. Fiebich
机构
[1] University of Freiburg Medical School,Department of Psychiatry
来源
关键词
Prostaglandin E; EP1; prostanoid receptors; rat brain; cerebellum; Purkinje cells; cyclooxygenase; neuroimmunology;
D O I
暂无
中图分类号
学科分类号
摘要
Prostaglandin E2 (PGE2), is a major prostanoid produced by the activity of cyclooxygenases (COX) in response to various physiological and pathological stimuli. PGE2 exerts its effects by activating four specific E-type prostanoid receptors (EP1, EP2, EP3, and EP4). In the present study, we analyzed the expression of the PGE2 receptor EP1 (mRNA and protein) in different regions of the adult rat brain (hippocampus, hypothalamus, striatum, prefrontal cerebral cortex, parietal cortex, brain stem, and cerebellum) using reverse transcriptionpolymerase chain reaction, Western blotting, and immunohistochemical methods. On a regional basis, levels of EP1 mRNA were the highest in parietal cortex and cerebellum. At the protein level, we found very strong expression of EP1 in cerebellum, as revealed by Western blotting experiments. Furthermore, the present study provides for the first time evidence that the EP1 receptor is highly expressed in the cerebellum, where the Purkinje cells displayed very high immunolabeling of their perikaryon and dendrites, as observed in the immunohistochemical analysis. Results from the present study indicate that the EP1 prostanoid receptor is expressed in specific neuronal populations, which possibly determine the region-specific response to PGE2.
引用
收藏
页码:303 / 310
页数:7
相关论文
共 50 条
  • [31] Mechanistic studies of the metastasis suppressor prostaglandin E2 receptor EP1 in breast cancer
    Reader, Jocelyn C.
    Ma, Xinrong
    Kundu, Namita
    Goloubeva, Olga
    Fulton, Amy
    CANCER RESEARCH, 2013, 73 (08)
  • [32] Prostaglandin E2 modulates midbrain dopaminergic system via its receptor EP1
    Tanaka, Y
    Furuyashiki, T
    Matsuoka, T
    Kitaoka, S
    Nagai, T
    Yamada, K
    Mizoguchi, A
    Nishi, A
    Nabeshima, T
    Narumiya, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 273P - 273P
  • [33] The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure
    Stock, JL
    Shinjo, K
    Burkhardt, J
    Roach, M
    Taniguchi, K
    Ishikawa, T
    Kim, HS
    Flannery, PJ
    Coffman, TM
    McNeish, JD
    Audoly, LP
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03): : 325 - 331
  • [34] Role of the prostaglandin E2 receptor subtype EP1 in cisplatin-induced nephrotoxicity
    Kojima, Fumiaki
    Yuhki, Koh-ichi
    Kashiwagi, Hitoshi
    Kumei, Shima
    Narumiya, Shuh
    Ushikubi, Fumitaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 167P - 167P
  • [35] Role of prostaglandin E2 (PGE2) receptor EP1 in blood pressure regulation
    Guan, YF
    Zhang, YH
    Yang, GR
    Breyer, R
    Breyer, M
    HYPERTENSION, 2004, 44 (04) : 544 - 544
  • [36] Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells
    Bo Sun
    Rong Rong
    Hai Jiang
    Hai Zhang
    YiPin Wang
    Xiaoming Bai
    Min Zhang
    Juan Ma
    Shukai Xia
    Wei Shu
    Li Zhang
    Jing Leng
    Molecular and Cellular Biochemistry, 2013, 378 : 195 - 203
  • [37] Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells
    Sun, Bo
    Rong, Rong
    Jiang, Hai
    Zhang, Hai
    Wang, YiPin
    Bai, Xiaoming
    Zhang, Min
    Ma, Juan
    Xia, Shukai
    Shu, Wei
    Zhang, Li
    Leng, Jing
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 378 (1-2) : 195 - 203
  • [38] Prostaglandin E2 Enhances B-Type Natriuretic Peptide Receptor Expression in Calvarial Osteoblasts through EP1 Subtype of Prostaglandin E2 Receptor
    Kaneki, Hiroyuki
    Kurokawa-Nagai, Maki
    Sugano, Yuri
    Ishi-i, Gaku
    Kurokawa, Minoru
    Ide, Hayao
    JOURNAL OF HEALTH SCIENCE, 2009, 55 (02) : 226 - 232
  • [39] Prostaglandin E2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats
    Hosoi, M
    Oka, T
    Abe, M
    Hori, T
    Yamamoto, H
    Mine, K
    Kubo, C
    PAIN, 1999, 83 (02) : 221 - 227
  • [40] SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL
    Tsujisawa, T
    Inoue, H
    Nishihara, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 15 - 22